Press Releases
April 25, 2023
CytomX Therapeutics to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ
Additional Formats
March 27, 2023
CytomX Therapeutics Reports Full Year 2022 Financial Results and Provides Business Update
Additional Formats
March 22, 2023
CytomX Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on March 27, 2023
Additional Formats
February 28, 2023
CytomX Therapeutics to Present at Upcoming March Investor Conferences
Additional Formats
January 26, 2023
CytomX Therapeutics Announces Milestone Achievement in Probody® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas
Additional Formats
January 17, 2023
CytomX Therapeutics to Present at the B. Riley Securities Virtual Annual Oncology Investor Conference
Additional Formats
January 5, 2023
CytomX and Moderna Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics
Additional Formats
January 5, 2023
CytomX Therapeutics Provides Business Update and Outlines 2023 Company Priorities
Additional Formats
Displaying 11 - 18 of 18